1. Within your health trust how many patients are currently [within the past 6 months] being treated with a chemotherapy agent [not including surgery/radiotherapy only];

a. All Non-Small Cell Lung Cancer patients
b. Patients with Non-Small Cell Lung Cancer (NSCLC) Stage IIIB**/IV** (Stage 3b/4)

c. Of the NSCLC patients, please state the number of patients currently [within the past 6 months] being treated with the following therapies;
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Nitendaninb + docetaxel
Nivolumab (Opdivo)
Pemetrexed (Alimta) mono or in combination with carboplatin / cisplatin
Pembrolizumab (Keytruda)
Gemcitabine mono or in combination with carboplatin / cisplatin
Paclitaxel mono or in combination with carboplatin / cisplatin
Doxetaxel mono or in combination with carboplatin / cisplatin
Vinorelbine [or other Vinka alkaloid] mono or in combination with carboplatin / Cisplatin

Download response Non-Small Cell Lung Cancer. 300317